Delayed-onset dementia after stroke or transient ischemic attack

Alzheimer's and Dementia

Volumn 12, Issue 11, 2016, Pages 1167-1176

  Mok, Vincent C T ^a,b   Lam, Bonnie Y K ^a,b   Wang, Zhaolu ^a   Liu, Wenyan ^a   Au, Lisa ^a   Leung, Eric Y L ^c   Chen, Sirong ^c   Yang, Jie ^d   Chu, Winnie C W ^a   Lau, Alexander Y L ^a   Chan, Anne Y Y ^a   Shi, Lin ^a   Fan, Florence ^a   Ma, Sze H ^a   Ip, Vincent ^a   Soo, Yannie O Y ^a   Leung, Thomas W H ^a   Kwok, Timothy C Y ^a   Ho, Chi L ^c   Wong, Lawrence K S ^a   Wong, Adrian ^a,b   more..

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b Therese Pei Fong Chow Research Centre for Prevention of Dementia   (China)

^c HONG KONG SANATORIUM AND HOSPITAL   (Hong Kong)

^d GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Delayed onset dementia; Small vessel disease; Stroke; Transient ischemic attack

Indexed keywords

BIOLOGICAL MARKER; APOLIPOPROTEIN E; DIETHYL-1,3,6,8-TETRAHYDRO-1,3,6,8-TETRAOXOBENZO(LMN)(3,8)PHENANTHROLINE-2,7-DIACETATE; FLUORODEOXYGLUCOSE F 18; PHENANTHROLINE DERIVATIVE;

AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DIABETES MELLITUS; DISEASE SEVERITY; EDUCATION; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NEUROIMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; TRANSIENT ISCHEMIC ATTACK; WHITE MATTER; ADULT; BRAIN; COMPLICATION; DIAGNOSTIC IMAGING; FOLLOW UP; GENETICS; LONGITUDINAL STUDY; MIDDLE AGED; POSITRON EMISSION TOMOGRAPHY; PSYCHOLOGY; TIME FACTOR; VERY ELDERLY; X-RAY COMPUTED TOMOGRAPHY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; APOLIPOPROTEINS E; BRAIN; DEMENTIA; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; ISCHEMIC ATTACK, TRANSIENT; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PHENANTHROLINES; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; STROKE; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 84994387451     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2016.05.007     Document Type: Article

References (35)

1. [1] Ferri, C.P., Prince, M., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., et al. Global prevalence of dementia: a Delphi consensus study. Lancet 366 (2005), 2112–2117.
2. [2] Pendlebury, S.T., Rothwell, P.M., Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol 8 (2009), 1006–1018.
3. [3] Levine, D., Galecki, A., Langa, K., Unverzagt, F., Kabeto, M., Giordani, B., et al. Trajectory of cognitive decline after incident stroke. JAMA 314 (2015), 41–51.
4. [4] Hénon, H., Durieu, I., Guerouaou, D., Lebert, F., Pasquier, F., Leys, D., Poststroke dementia: incidence and relationship to prestroke cognitive decline. Neurology 57 (2001), 1216–1222.
5. [5] Altieri, M., Di Piero, V., Pasquini, M., Gasparini, M., Vanacore, N., Vicenzini, E., et al. Delayed poststroke dementia: a 4-year follow-up study. Neurology 62 (2004), 2193–2197.
6. [6] Allan, L.M., Rowan, E.N., Firbank, M.J., Thomas, A.J., Parry, S.W., Polvikoski, T.M., et al. Long term incidence of dementia, predictors of mortality and pathological diagnosis in older stroke survivors. Brain 134 (2011), 3716–3727.
7. [7] Srikanth, V.K., Quinn, S.J., Donnan, G.A., Saling, M.M., Thrift, A.G., Long-term cognitive transitions, rates of cognitive change, and predictors of incident dementia in a population-based first-ever stroke cohort. Stroke 37 (2006), 2479–2483.
8. [8] Andersen, G., Vestergaard, K., Østergaard Riis, J., Ingeman-Nielsen, M., Intellectual impairment in the first year following stroke, compared to an age-matched population sample. Cerebrovasc Dis 6 (1996), 363–369.
9. [9] Inzitari, D., Di Carlo, A., Pracucci, G., Lamassa, M., Vanni, P., Romanelli, M., et al. Incidence and determinants of poststroke dementia as defined by an informant interview method in a hospital-based stroke registry. Stroke 29 (1998), 2087–2093.
10. [10] Narasimhalu, K., Ang, S., De Silva, D.A., Wong, M.C., Chang, H.M., Chia, K.S., et al. Severity of CIND and MCI predict incidence of dementia in an ischemic stroke cohort. Neurology 73 (2009), 1866–1872.
11. [11] Tatemichi, T., Paik, M., Bagiella, E., Desmond, D., Stern, Y., Sano, M., et al. Risk of dementia after stroke in a hospitalized cohort: results of a longitudinal study. Neurology 44 (1994), 1885–1991.
12. [12] Nakano, Y., Deguchi, K., Yamashita, T., Morihara, R., Matsuzono, K., Kawahara, Y., et al. High incidence of dementia conversion than stroke recurrence in poststroke patients of late elder society. J Stroke Cerebrovasc Dis 24 (2015), 1621–1628.
13. [13] Sachdev, P.S., Lipnicki, D.M., Crawford, J.D., Wen, W., Brodaty, H., Progression of cognitive impairment in stroke/TIA patients over 3 years. J Neurol Neurosurg Psychiatry 85 (2014), 1324–1330.
14. [14] Desmond, D.W., Moroney, J.T., Sano, M., Stern, Y., Incidence of dementia after ischemic stroke: results of a longitudinal study. Stroke 33 (2002), 2254–2262.
15. [15] Kokmen, E., Whisnant, J.P., O'Fallon, W.M., Chu, C.P., Beard, C.M., Dementia after ischemic stroke: a population-based study in Rochester, Minnesota (1960-1984). Neurology 46 (1996), 154–159.
16. [16] Tatemichi, T.K., Foulkes, M.A., Mohr, J.P., Hewitt, J.R., Hier, D.B., Price, T.R., et al. Dementia in stroke survivors in the Stroke Data Bank cohort. Prevalence, incidence, risk factors, and computed tomographic findings. Stroke 21 (1990), 858–866.
17. [17] Diener, H.C., Sacco, R.L., Yusuf, S., Cotton, D., Ôunpuu, S., Lawton, W.A., et al. Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study. Lancet Neurol 7 (2008), 875–884.
18. [18] Tzourio, C., Anderson, C., Chapman, N., Woodward, M., Neal, B., MacMahon, S., et al. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med 163 (2003), 1069–1075.
19. [19] Firbank, M.J., Burton, E.J., Barber, R., Stephens, S., Kenny, R.A., Ballard, C., et al. Medial temporal atrophy rather than white matter hyperintensities predict cognitive decline in stroke survivors. Neurobiol Aging 28 (2007), 1664–1669.
20. [20] Hénon, H., Pasquier, F., Durieu, I., Godefroy, O., Lucas, C., Lebert, F., et al. Preexisting dementia in stroke patients: baseline frequency, associated factors, and outcome. Stroke 28 (1997), 2429–2436.
21. [21] Gorelick, P.B., Nyenhuis, D.L., Garron, D.C., Cochran, E., Is vascular dementia really Alzheimer's disease or mixed dementia?. Neuroepidemiology 15 (1996), 286–290.
22. [22] Mok, V., Xiong, Y., Wong, K.K., Wong, A., Schmidt, R., Chu, W.W., et al. Predictors for cognitive decline in patients with confluent white matter hyperintensities. Alzheimers Dement 8 (2012), S96–S103.
23. [23] Yang, J., Wong, A., Wang, Z., Liu, W., Au, L., Xiong, Y., et al. Risk factors for incident dementia after stroke and transient ischemic attack. Alzheimers Dement 11 (2015), 16–23.
24. [24] Wang, Y., Griffith, J., Zeng, X., Deng, M., Kwok, A., Leung, J.C., et al. Prevalence and gender difference of lumbar disc space narrowing in elderly Chinese men and women: Mr. OS (Hong Kong) and Ms. OS (Hong Kong) studies. Arthritis Rheum 65 (2013), 1004–1010.
25. [25] Rothwell, P.M., Howard, S.C., Dolan, E., O'Brien, E., Dobson, J.E., Dahlöf, B., et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 375 (2010), 895–905.
26. [26] Sacco, R.L., Kasner, S.E., Broderick, J.P., Caplan, L.R., Connors, J.J., Culebras, A., et al. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 44 (2013), 2064–2089.
27. [27] Chiu, H.F.K., Lee, H.C., Chung, W.S., Kwong, P.K., Reliability and validity of the Cantonese version of Mini-mental state examination—a preliminary study. Hong Kong J Psychiatry 4 (1994), 25–28.
28. [28] Wong, A., Xiong, Y.Y., Kwan, P.W., Chan, A.Y., Lam, W.W., Wang, K., et al. The validity, reliability and clinical utility of the Hong Kong Montreal Cognitive Assessment (HK-MoCA) in patients with cerebral small vessel disease. Dement Geriatr Cogn Disord 28 (2009), 81–87.
29. [29] Woo, J., Ho, S., Lau, J., Yuen, Y., Chiu, H., Lee, H., et al. The prevalence of depressive symptoms and predisposing factors in an elderly Chinese population. Acta Psychiatr Scand 89 (1994), 8–13.
30. [30] van Dijk, E.J., Prins, N.D., Vrooman, H.A., Hofman, A., Koudstaal, P.J., Breteler, M.M., Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences: Rotterdam Scan Study. Stroke 39 (2008), 2712–2719.
31. [31] Mok, V., Wong, K.K., Xiong, Y., Wong, A., Schmidt, R., Chu, W., et al. Cortical and frontal atrophy are associated with cognitive impairment in age-related confluent white-matter lesion. J Neurol Neurosurg Psychiatry 82 (2011), 52–57.
32. [32] Liu, Y., Yu, J., Wang, H., Han, P., Tan, C., Wang, C., et al. APOE genotype and neuroimaging markers of Alzheimer's disease: systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 86 (2015), 127–134.
33. [33] Pendlebury, S.T., Rothwell, P.M., Risk of recurrent stroke, other vascular events and dementia after transient ischaemic attack and stroke. Cerebrovasc Dis 27 (2009), 1–11.
34. [34] Pearce, L.A., McClure, L.A., Anderson, D.C., Jacova, C., Sharma, M., Hart, R.G., et al. Effects of long-term blood pressure lowering and dual antiplatelet treatment on cognitive function in patients with recent lacunar stroke: a secondary analysis from the SPS3 randomised trial. Lancet Neurol 13 (2014), 1177–1185.
35. [35] Biessels, G.J., Staekenborg, S., Brunner, E., Brayne, C., Scheltens, P., Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 5 (2006), 64–74.